Results 291 to 300 of about 68,566 (325)
Hypertension in Living Kidney Donors Has No Effect on Complement Activation and Fibrosis.
Wagner N+7 more
europepmc +1 more source
Complement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampus
Nguyen VD+4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pharmacological Research, 2022
The pathological features of inflammatory bowel disease necessitate therapeutic strategies aimed at restoring intestinal mucosal barrier function in addition to controlling inflammation. Paeoniflorin, a bioactive herbal constituent isolated from the root
Yirui Wang+19 more
semanticscholar +1 more source
The pathological features of inflammatory bowel disease necessitate therapeutic strategies aimed at restoring intestinal mucosal barrier function in addition to controlling inflammation. Paeoniflorin, a bioactive herbal constituent isolated from the root
Yirui Wang+19 more
semanticscholar +1 more source
C1q, antibodies and anti-C1q autoantibodies
Molecular Immunology, 2015The complement system has long been known for its role in combating infections. More recently the complement system is becoming increasingly appreciated for its role in processes that range from waste transport, immune tolerance and shaping of the adaptive immune response.
Beurskens, F.J.+2 more
openaire +4 more sources
C1q-binding proteins and C1q receptors
Current Opinion in Immunology, 1999Aggregated or immobilized complement C1q induces cellular responses in many different cell types. C1q-induced cellular responses may be involved in host defense and in protection against autoimmunity because C1q-deficient humans have infectious complications and a very high incidence of autoimmune disease.
Lloyd B. Klickstein+1 more
openaire +3 more sources
Macrophage C1q: characterization of a membrane form of C1q and of multimers of C1q subunits.
The Journal of Immunology, 1987Abstract It has been shown recently that C1q, a subcomponent of the first component of the classical complement pathway, is synthesized by macrophages and that endogenous C1q is detectable on the macrophage membrane. In this report, we demonstrate that membrane-associated C1q, which contains the A, B, and C chains of C1q ...
H, Martin, H P, Heinz, K, Reske, M, Loos
openaire +2 more sources
C1q binding and C1q deviation assays using enzyme labelled C1q
Journal of Immunological Methods, 1984Methods for the enzyme labelling of C1q are described. The C1q conjugates have been incorporated into suitably modified C1q deviation and C1q binding assays for circulating immune complexes. These assays show the expected high positivity rate in sera from patients with systemic lupus erythematosus.
G.W. Smith, I.J. Simpson, M.J. Myles
openaire +3 more sources
RAGE binds C1q and enhances C1q-mediated phagocytosis
Cellular Immunology, 2012RAGE, the multiligand receptor of the immunoglobulin superfamily of cell surface molecules, is implicated in innate and adaptive immunity. Complement component C1q serves roles in complement activation and antibody-independent opsonization. Using soluble forms of RAGE (sRAGE) and RAGE-expressing cells, we determined that RAGE is a native C1q globular ...
Fei Song+5 more
openaire +2 more sources
Pediatric Nephrology, 2005
C1q nephropathy (C1qNP) is a peculiar form of glomerulonephritis characterized by mesangial immunoglobulin and complement deposits, predominantly C1q, with no evidence of systemic lupus erythematosus. We describe the incidence, manifestation, histopathologic findings, follow-up, treatment and outcome of C1qNP.
Mojca Avguštin Čavić+5 more
openaire +3 more sources
C1q nephropathy (C1qNP) is a peculiar form of glomerulonephritis characterized by mesangial immunoglobulin and complement deposits, predominantly C1q, with no evidence of systemic lupus erythematosus. We describe the incidence, manifestation, histopathologic findings, follow-up, treatment and outcome of C1qNP.
Mojca Avguštin Čavić+5 more
openaire +3 more sources